Robinhood stock slides after-hours as order-flow settlement notice hits wires, traders eye earnings

Robinhood stock slides after-hours as order-flow settlement notice hits wires, traders eye earnings

New York, Jan 6, 2026, 18:00 ET — After-hours

  • Shares down 1.2% after hours, extending a choppy start to 2026
  • Settlement administrator published details of a proposed $2 million order-flow case resolution
  • Next big marker: Feb. 10 results, with U.S. labor data due Wednesday

Robinhood Markets shares slipped 1.2% in after-hours trading on Tuesday after a settlement administrator published details of a proposed $2 million resolution in long-running “order flow” litigation. The stock was last at $121.70. GlobeNewswire

The notice matters because it reopens scrutiny of how trades get routed and priced — a sensitive issue for retail brokerages. The case focuses on market orders executed at worse prices than the “national best bid or offer,” the top quoted prices in public markets.

The legal update landed as investors continue to trade Robinhood as a proxy for risk appetite in digital assets and high-turnover retail trading. On Tuesday, Morgan Stanley filed for bitcoin and solana exchange-traded funds, another sign traditional finance is pushing deeper into crypto products. Reuters

Robinhood has been trying to hold on to heavier traders by sharpening its crypto tools, according to a report that cited Johann Kerbrat, head of crypto at Robinhood. Kerbrat said some newer customers see dips as “‘buy the dip’ opportunities,” while more sophisticated users trade more actively. Whalesbook

Investors also have an earnings checkpoint coming up. Robinhood said it will report fourth-quarter and full-year 2025 results on Feb. 10, after the close, with Chief Executive Vlad Tenev and incoming Chief Financial Officer Shiv Verma scheduled to discuss results on a video call. GlobeNewswire

Technicians note the stock is hovering around key trend lines, trading above its 50-day moving average of about $117.75 but below the 200-day moving average near $123.06, according to Investing.com. The stock’s 52-week range runs from $29.66 to $153.86, Yahoo Finance data showed. Investing

Still, the downside case is straightforward: legal and regulatory friction around order execution can raise costs or curb product flexibility, while swings in crypto prices can quickly cool trading volumes. Either can squeeze transaction-driven revenue and weigh on sentiment.

What investors watch next is Wednesday’s U.S. Job Openings and Labor Turnover Survey (JOLTS) report at 10:00 a.m. ET and a Federal Reserve speech later in the day — both potential inputs for rate expectations that can sway higher-beta growth stocks. Bls

Stock Market Today

  • Panacea Biotec stock jumps 28% in 30 days as investor sentiment improves; P/S near industry median
    January 8, 2026, 7:33 PM EST. Panacea Biotec Ltd. shares have rallied 28% in the last 30 days, a rebound that returns the stock to levels from a year ago. The move suggests investor sentiment has shifted, even as long-term holders question whether the gain simply reverses recent losses. The P/S ratio sits around 4.4x, close to the industry median of about 4.5x in India's biotech sector. Revenue has risen, with a 9.8% year-over-year gain and an 18% lift from three years ago. Industry forecasts imply stronger growth, making the P/S a reflection of sentiment as much as value. No published analyst estimates are available for Panacea Biotec.
Intel stock rises after hours as CES “Panther Lake” debut and Melius upgrade sharpen focus on 18A
Previous Story

Intel stock rises after hours as CES “Panther Lake” debut and Melius upgrade sharpen focus on 18A

MSCI hits pause on crypto index kick-out plan — Strategy pops after-hours
Next Story

MSCI hits pause on crypto index kick-out plan — Strategy pops after-hours

Go toTop